Intensive pediatric chemotherapy regimen (PNET HR+5) in adult high-risk medulloblastoma and pineoblastoma patients
Neurooncol Adv. 2024 Aug 10;6(1):vdae141. doi: 10.1093/noajnl/vdae141. eCollection 2024 Jan-Dec. ABSTRACT BACKGROUND: High-risk medulloblastoma (HRMB) is rare in adults. The 5-year overall survival rate is …